drugset / Trial / NCT00595673

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

NCT00595673 ↗

Phase 3 Completed 428 enrolled Point Biomedical
NaSingle-groupOpen-labelDiagnostic

Summary

This trial is to compare PB127 echocardiography to other heart imaging studies.

Timeline

Start
2002-07
Primary completion
2003-10
Completion
2003-10

Drugs

EvaluationDrugModalityDoseRoute
Subject PB127 Diagnostic / imaging agent 0.175 mg/kg Intravenous